<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis - Chande, N - 2015 | Cochrane Library</title> <meta content="Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis - Chande, N - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006774.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis - Chande, N - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006774.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006774.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis" name="citation_title"/> <meta content="Nilesh Chande" name="citation_author"/> <meta content="London Health Sciences Centre ‐ Victoria Hospital" name="citation_author_institution"/> <meta content="nilesh.chande@lhsc.on.ca" name="citation_author_email"/> <meta content="Yongjun Wang" name="citation_author"/> <meta content="Robarts Research Institute" name="citation_author_institution"/> <meta content="John WD McDonald" name="citation_author"/> <meta content="Robarts Research Institute" name="citation_author_institution"/> <meta content="John K MacDonald" name="citation_author"/> <meta content="Robarts Research Institute" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD006774.pub4" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/08/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006774.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006774.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006774.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [adverse effects, *therapeutic use]; Colitis, Ulcerative [*drug therapy]; Delayed‐Action Preparations [adverse effects, therapeutic use]; Heparin [adverse effects, *therapeutic use]; Heparin, Low‐Molecular‐Weight [adverse effects, therapeutic use]; Injections, Subcutaneous; Intention to Treat Analysis; Randomized Controlled Trials as Topic; Remission Induction [methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006774.pub4&amp;doi=10.1002/14651858.CD006774.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="PMzGcYGP";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006774\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006774\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006774.pub4",title:"Unfractionated or low\\u2010molecular weight heparin for induction of remission in ulcerative colitis",firstPublishedDate:"Aug 5, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006774.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006774.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006774.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006774.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006774.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006774.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006774.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006774.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006774.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006774.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>780 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006774.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0031"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0026"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-sec-0030"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/appendices#CD006774-sec-0036"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/table_n/CD006774StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/table_n/CD006774StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#CD006774-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Nilesh Chande</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#CD006774-cr-0003">Yongjun Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#CD006774-cr-0004">John WD McDonald</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information#CD006774-cr-0005">John K MacDonald</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information/en#CD006774-sec-0039">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 August 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006774.pub4">https://doi.org/10.1002/14651858.CD006774.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006774-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006774-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006774-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006774-abs-0005">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006774-abs-0001" lang="en"> <section id="CD006774-sec-0001"> <h3 class="title" id="CD006774-sec-0001">Background</h3> <p>There are a limited number of treatment options for patients with ulcerative colitis (UC). An increased risk of thrombosis in UC coupled with an observation that UC patients being treated with anticoagulant therapy for thrombotic events had an improvement in their bowel symptoms led to trials examining the use of unfractionated heparin (UFH) and low molecular weight heparins (LMWH) in patients with active UC. </p> </section> <section id="CD006774-sec-0002"> <h3 class="title" id="CD006774-sec-0002">Objectives</h3> <p>To review randomized trials examining the efficacy of unfractionated heparin (UFH) or low molecular weight heparins (LMWH) for remission induction in patients with ulcerative colitis. </p> </section> <section id="CD006774-sec-0003"> <h3 class="title" id="CD006774-sec-0003">Search methods</h3> <p>We searched MEDLINE, EMBASE, CENTRAL, and the Cochrane IBD/FBD group specialized trials register up to June 2014. We also searched review papers on ulcerative colitis and references from identified papers in an effort to identify additional randomized trials studying UFH or LMWH use in patients with ulcerative colitis. We searched abstracts from major gastroenterological meetings to identify research published in abstract form. </p> </section> <section id="CD006774-sec-0004"> <h3 class="title" id="CD006774-sec-0004">Selection criteria</h3> <p>Randomized controlled trials comparing UFH or LMWH to placebo or a control therapy for induction of remission in ulcerative colitis were included. Studies published in abstract form only were included if the authors could be contacted for further information. </p> </section> <section id="CD006774-sec-0005"> <h3 class="title" id="CD006774-sec-0005">Data collection and analysis</h3> <p>A data extraction form was developed and used to extract data from included studies. Two authors independently extracted data. Any disagreements were resolved by consensus. The Cochrane Risk of Bias tool was used to assess study quality. Data were analyzed on an intention‐to‐treat basis. The primary outcome was induction of remission, as defined by the studies. Secondary outcomes measures included: endoscopic remission as defined by the authors; clinical, histological or endoscopic improvement as defined by the authors; the occurrence of adverse events; the occurrence of bleeding; and improvements in quality of life as measured by a validated instrument. We calculated the risk ratio (RR) and corresponding 95% confidence interval for dichotomous outcomes. Data were combined for analysis if they assessed the same treatments (UFH or LMWH versus placebo or other therapy). The overall quality of the evidence supporting the outcomes was evaluated using the GRADE criteria. </p> </section> <section id="CD006774-sec-0006"> <h3 class="title" id="CD006774-sec-0006">Main results</h3> <p>Five studies were eligible for inclusion (329 patients). Three studies (270 patients) compared low molecular weight heparin to placebo, one study (34 patients) compared LMWH in addition to standard therapy, and one study (25 patients) compared UFH to corticosteroids. The study comparing UFH to corticosteroids was rated at high risk of bias due to a single‐blind design. The study that compared the addition of LMWH to standard therapy to standard therapy alone was rated at high risk of bias due to open‐label design. The other three studies were rated as low risk of bias. LMWH administered subcutaneously showed no benefit over placebo for any outcome, including clinical remission (very low quality of evidence), and clinical, endoscopic, or histological improvement. High dose LMWH administered via an extended colon‐release tablet demonstrated benefit over placebo for clinical remission (RR 1.39; 95% CI 1.09 to 1.77 ; P = 0.008; very low quality of evidence), clinical improvement (RR 1.28; 95% CI 1.06 to 1.55; P = 0.01; very low quality of evidence), and endoscopic improvement (RR 1.21; 95% CI 1.00 to 1.47 ; P = 0.05) but not endoscopic remission or histologic improvement. LMWH was not beneficial when added to standard therapy for clinical remission, clinical improvement, endoscopic remission or endoscopic improvement. LMWH was well‐tolerated but provided no significant benefit for quality of life. One study examining UFH versus corticosteroids for the treatment of severe UC demonstrated the inferiority of UFH for clinical improvement. More patients assigned to UFH had rectal hemorrhage as an adverse event. </p> </section> <section id="CD006774-sec-0007"> <h3 class="title" id="CD006774-sec-0007">Authors' conclusions</h3> <p>There is evidence to suggest that LMWH may be effective for the treatment of active UC. When administered by extended colon‐release tablets, LMWH was more effective than placebo for treating outpatients with mild to moderate disease. This benefit needs to be confirmed by further randomized controlled studies. The same benefits were not seen when LMWH was administered subcutaneously at lower doses. There is no evidence to support the use of UFH for the treatment of active UC. A further trial of UFH in patients with mild disease may also be justified. Any benefit found would need to be weighed against a possible increased risk of rectal bleeding in patients with active UC. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006774-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006774-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006774-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006774-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006774-abs-0002" lang="en"> <h3>Unfractionated or low molecular weight heparin for treatment of active ulcerative colitis </h3> <p><b>Review Question</b> </p> <p>We reviewed the evidence about the effects of unfractionated or low‐molecular weight heparin on induction of remission in patients with ulcerative colitis, with the medical literature up to June 17, 2014. </p> <p><b>Background</b> </p> <p>What is ulcerative colitis?</p> <p>Ulcerative colitis is a chronic inflammatory bowel disease characterized by recurrent episodes of active disease, which commonly affect the rectum or colon or both. Patients with active disease may experience abdominal cramping, urgency to pass stools, and bloody diarrhea. When the symptoms stop, the patients enter a 'remission phase' of ulcerative colitis. </p> <p>What is heparin?</p> <p>Heparin is a family of medications that reduce the body's natural ability to form clots. Unfrationated and low‐molecular heparins are sub‐types of heparins that are currently available for clinical use. In theory, decreasing clot formation may help to improve symptoms of ulcerative colitis. </p> <p><b>Study Characteristics</b> </p> <p>The researchers identified five studies that included a total of 329 patients. Three studies (270 patients) compared low molecular weight heparin to placebo (e.g. a sugar pill), one study (34 patients) compared low molecular weight heparin in addition to standard therapy, and one study (25 patients) compared unfractionated heparin to steroids. The study comparing unfractionated heparin to steroids and the study that compared the addition of low molecular weight heparin to standard therapy to standard therapy alone was judged to be of low quality. The three placebo‐controlled studies were judged to be of high quality. </p> <p><b>Key Results</b> </p> <p>In one small study, unfractionated heparin was worse than steroids for inducing clinical improvement (i.e. reduction of symptoms) in people with severe ulcerative colitis. In addition, rectal bleeding was more frequent among people who received unfractionated heparin. In another small study low molecular weight heparin used with standard therapy provided no additional benefit over standard therapy alone in adults with active ulcerative colitis. </p> <p>Low molecular weight heparin administered by injection showed no benefit over placebo for any outcome, including clinical remission (very low quality of evidence), clinical improvement and endoscopic improvement (i.e. healing of inflammation). High dose low molecular weight heparin administered via an extended colon‐release tablet demonstrated benefit over placebo for clinical remission, clinical improvement. and endoscopic improvement. This result suggests that high dose low molecular weight heparin administered by extended‐release capsules may be effective for the treatment of active ulcerative colitis. However, this result needs to be verified by future clinical trials. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006774-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006774-sec-0031"></div> <h3 class="title" id="CD006774-sec-0032">Implications for practice</h3> <section id="CD006774-sec-0032"> <p>There is evidence to suggest that LMWH may be effective for the treatment of active UC. When administered by extended colon‐release tablets, LMWH was more effective than placebo for treating outpatients with mild to moderate disease. This benefit needs to be confirmed with further randomized controlled trials by independent researchers with minimal industry involvement. The same benefits were not seen when LMWH was administered subcutaneously at lower doses. UFH is inferior to corticosteroids for treating patients with moderate or severe disease and does not lead to clinical improvement in these patients. Whether or not UFH would be effective for treating patients with milder disease is uncertain, although the potential for worsening rectal bleeding may be significant. </p> </section> <h3 class="title" id="CD006774-sec-0033">Implications for research</h3> <section id="CD006774-sec-0033"> <p>Patients with UC have an increased risk of thrombosis (<a href="./references#CD006774-bbs2-0033" title="BernsteinCN , BlanchardJF , HoustonDS , WajdaA . The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population‐based cohort study. Thromb Haemost2001;85(3):430‐4. [PUBMED: 11307809] ">Bernstein 2001</a>). This may be related to an increased rate of coexisting coagulopathies (<a href="./references#CD006774-bbs2-0038" title="HudsonM , ChitolieA , HuttonRA , SmithMS , PounderRE , WakefieldAJ . Thrombotic vascular risk factors in inflammatory bowel disease. Gut1996;38(5):733‐7. [PUBMED: 8707120] ">Hudson 1996</a>, <a href="./references#CD006774-bbs2-0048" title="SoutoJC , MartinezE , RocaM , MateoJ , PujolJ , GonzalezD , et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci1995;40(9):1883‐9. [PUBMED: 7555437] ">Souto 1995</a>). The possibility that microthrombosis plays a role in the pathogenesis of UC led to trials examining the use of UFH and LMWH for the treatment of UC (<a href="./references#CD006774-bbs2-0035" title="DhillonAP , AnthonyA , SimR , WakefieldAJ , SankeyEA , HudsonM , et al. Mucosal capillary thrombi in rectal biopsies. Histopathology1992;21(2):127‐33. [PUBMED: 1505929] ">Dhillon 1992</a>). These trials have demonstrated therapeutic benefit of LMWH administered via oral extended colon‐release tablets, but not through the subcutaneous route. Further studies of the therapeutic efficacy of oral heparin formulations in active UC may be warranted. The efficacy of rectally administered LMWH (i.e. enema) has not been studied and should also be investigated (<a href="./references#CD006774-bbs2-0044" title="LuoJ , CaoJ , JiangX , CuiH . Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice. Biomed Pharmacother2010;64(7):441‐5. [PUBMED: 20359854] ">Luo 2010</a>). The utility of UFH in mild disease has been studied, but the final results are not known (<a href="./references#CD006774-bbs2-0019" title="KorzenikJR , RobertME , BittonA , RobinsonM , ScherlEJ , FisherRL , et al. A multicenter, randomized, controlled trial of heparin for the treatment of ulcerative colitis. Gastroenterology1999;116(4 Part 2):A752. ">Korzenik 1999</a>). The pathophysiology of UC and the possible link between microthrombosis and immune activation in the colon should be further investigated. Other therapeutic targets may be identified which could be important in developing novel treatments for UC. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006774-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006774-sec-0015"></div> <div class="table" id="CD006774-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">LMWH compared to Placebo for induction of remission in ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>LMWH compared to Placebo for induction of remission in ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in ulcerative colitis<br/> <b>Settings:</b> Outpatient<br/> <b>Intervention:</b> LMWH<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> LMWH</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic remission</b> <br/> Follow‐up: mean 8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>157 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>211 per 1000</b> <br/> (104 to 427) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.34</b> <br/> (0.66 to 2.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control group risk comes from control arm of study<br/> <sup>2</sup> industry funded study and lack of sufficient details on central randomization<br/> <sup>3</sup> Very sparse data (26 events) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006774-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">LMWH + standard therapy compared to Standard therapy for induction of remission in ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>LMWH + standard therapy compared to Standard therapy for induction of remission in ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in ulcerative colitis<br/> <b>Settings:</b> Outpatient<br/> <b>Intervention:</b> LMWH + standard therapy<br/> <b>Comparison:</b> Standard therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Standard therapy </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> LMWH + standard therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical remission</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>389 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>311 per 1000</b> <br/> (124 to 793) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.8</b> <br/> (0.32 to 2.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical improvement</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>879 per 1000</b> <br/> (646 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b> <br/> (0.83 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic remission</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>389 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>311 per 1000</b> <br/> (124 to 793) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.8</b> <br/> (0.32 to 2.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic improvement</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>611 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>691 per 1000</b> <br/> (422 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b> <br/> (0.69 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control group risk comes from control arm of study<br/> <sup>2</sup> Open‐label trial (lack of blinding and allocation concealment)<br/> <sup>3</sup> Very sparse data (12 events)<br/> <sup>4</sup> Very sparse data (28 events)<br/> <sup>5</sup> Very sparse data (22 events) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006774-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">UFH compared to Corticosteroids for induction of remission in ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>UFH compared to Corticosteroids for induction of remission in ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in ulcerative colitis<br/> <b>Settings:</b> Outpatient<br/> <b>Intervention:</b> UFH<br/> <b>Comparison:</b> Corticosteroids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Corticosteroids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> UFH</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical improvement</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>692 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (0 to 609) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.06</b> <br/> (0 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control group risk comes from control arm of study<br/> <sup>2</sup> Single‐blind trial and lack of sufficient details on allocation concealment and randomization sequence<br/> <sup>3</sup> Very sparse data (9 events) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006774-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006774-sec-0016"></div> <p>Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a relatively limited number of treatment options. Traditional therapies include 5‐aminosalicylates and corticosteroids. Azathioprine is effective for maintenance of remission of quiescent disease (<a href="./references#CD006774-bbs2-0049" title="TimmerA , McDonaldJW , TsoulisDJ , MacDonaldJK . Azathioprine and 6‐mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD000478.pub3] ">Timmer 2012</a>), but its effectiveness for remission induction in patients with active disease is questionable (<a href="./references#CD006774-bbs2-0032" title="ArdizzoneS , MaconiG , RussoA , ImbesiV , ColomboE , Bianchi PorroG . Randomised controlled trial of azathioprine and 5‐aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut2006;55(1):47‐53. [PUBMED: 15972298] ">Ardizzone 2006</a>; <a href="./references#CD006774-bbs2-0036" title="HawthorneAB , LoganRF , HawkeyCJ , FosterPN , AxonAT , SwarbrickET , et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ1992;305(6844):20‐2. [PUBMED: 1638191] ">Hawthorne 1992</a>; <a href="./references#CD006774-bbs2-0039" title="JewellDP , TrueloveSC . Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J1974;4(5945):627‐30. [PUBMED: 4441827] ">Jewell 1974</a>). Infliximab is effective for induction and maintenance of remission in patients who have failed or not tolerated other therapies (<a href="./references#CD006774-bbs2-0040" title="LawsonMM , ThomasAG , AkobengAK . Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD005112.pub2] ">Lawson 2006</a>; <a href="./references#CD006774-bbs2-0046" title="RutgeertsP , SandbornB , FeaganBG , ReinischW , OlsonA , JohannsJ , et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med2005;353(23):2462‐76. [PUBMED: 16339095] ">Rutgeerts 2005</a>). Cyclosporine may be effective for treating patients with severe disease, but with significant potential for toxicity (<a href="./references#CD006774-bbs2-0047" title="ShiboletO , RegushevskayaE , BrezisM , Soares‐WeiserK . Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD004277.pub2] ">Shibolet 2005</a>). </p> <p>There is an increased risk of thrombosis in patients with ulcerative colitis (<a href="./references#CD006774-bbs2-0033" title="BernsteinCN , BlanchardJF , HoustonDS , WajdaA . The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population‐based cohort study. Thromb Haemost2001;85(3):430‐4. [PUBMED: 11307809] ">Bernstein 2001</a>). This may be due to an association with underlying coagulopathies (<a href="./references#CD006774-bbs2-0038" title="HudsonM , ChitolieA , HuttonRA , SmithMS , PounderRE , WakefieldAJ . Thrombotic vascular risk factors in inflammatory bowel disease. Gut1996;38(5):733‐7. [PUBMED: 8707120] ">Hudson 1996</a>; <a href="./references#CD006774-bbs2-0048" title="SoutoJC , MartinezE , RocaM , MateoJ , PujolJ , GonzalezD , et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci1995;40(9):1883‐9. [PUBMED: 7555437] ">Souto 1995</a>). Microthrombosis may also play a role in the pathogenesis of ulcerative colitis (<a href="./references#CD006774-bbs2-0035" title="DhillonAP , AnthonyA , SimR , WakefieldAJ , SankeyEA , HudsonM , et al. Mucosal capillary thrombi in rectal biopsies. Histopathology1992;21(2):127‐33. [PUBMED: 1505929] ">Dhillon 1992</a>). The finding of an improvement in bowel symptoms in ulcerative colitis patients treated with unfractionated heparin for acute thrombotic events led to hypotheses about the role of thrombosis in the pathogenesis of ulcerative colitis (<a href="./references#CD006774-bbs2-0030" title="ZavgorodniiLG , MustiatsAP . Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis [Primenenie antikoaguliantov v kompleksnom lechenii nespetsificheskogo iazvennogo kolita]. Klin Med (Mosk)1982;60(6):74‐80. [PUBMED: 7120895] ">Zavgorodnii 1982</a>). Subsequently, the potential role of unfractionated heparin and low molecular weight heparins in the treatment of patients with active ulcerative colitis was investigated. However, if a benefit were to be found, it would need to be balanced against the potential for worsening of rectal bleeding in patients with active ulcerative colitis treated with anticoagulants. This systematic review is an update of a previously published Cochrane review (<a href="./references#CD006774-bbs2-0050" title="ChandeN , McDonaldJW , MacDonaldJK . Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD006774.pub2] ">Chande 2008</a>; <a href="./references#CD006774-bbs2-0051" title="ChandeN , McDonaldJW , MacDonaldJK , WangJJ . Unfractionated or low‐molecular weight heparin for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD006774.pub3] ">Chande 2010</a>). </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006774-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006774-sec-0017"></div> <p>To review randomized trials examining the efficacy of unfractionated heparin (UFH) or low molecular weight heparins (LMWH) for remission induction in patients with ulcerative colitis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006774-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006774-sec-0018"></div> <section id="CD006774-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006774-sec-0020"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials comparing UFH or LMWH with placebo or an active comparator were considered for inclusion. Studies published as abstracts only were included if the authors could be contacted for further information. </p> </section> <section id="CD006774-sec-0021"> <h4 class="title">Types of participants</h4> <p>Adult patients with active ulcerative colitis defined by a combination of clinical, radiographic, endoscopic and histological criteria were included. </p> </section> <section id="CD006774-sec-0022"> <h4 class="title">Types of interventions</h4> <p>UFH or LMWH given by any route.</p> </section> <section id="CD006774-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p>The primary outcome measure was the number of patients achieving clinical remission and off steroids as defined by the studies and expressed as a percentage of the number of patients randomized (intention‐to‐treat analysis). Secondary outcomes measures included:<br/> a) Endoscopic remission as defined by the authors;<br/> b) Clinical, histological or endoscopic improvement as defined by the authors;<br/> c) The occurrence of adverse events;<br/> d) The occurrence of bleeding; and<br/> e) Improvements in quality of life as measured by a validated instrument. </p> </section> </section> <section id="CD006774-sec-0024"> <h3 class="title">Search methods for identification of studies</h3> <p>See: <a href="./appendices#CD006774-sec-0037">Appendix 1</a> for search strategy. </p> <p>The MEDLINE (PUBMED), and EMBASE databases, The Cochrane Central Register of Controlled Trials, the Cochrane IBD/FBD group specialized trials register, review papers on ulcerative colitis, and references from identified papers were searched up to June 17, 2014 in an effort to identify all randomized trials studying UFH or LMWH use in patients with ulcerative colitis. Abstracts from major gastroenterological meetings were searched to identify research published in abstract form only. </p> </section> <section id="CD006774-sec-0025"> <h3 class="title" id="CD006774-sec-0025">Data collection and analysis</h3> <p>Study selection<br/> Each author independently reviewed potentially relevant trials to determine their eligibility for inclusion based on the criteria identified above. Studies published in abstract form only were included if the authors could be contacted for further information. </p> <p>Data collection<br/> A data extraction form was developed and used to extract data from included studies. At least 2 authors independently extracted data. Any disagreements were resolved by consensus. </p> <p>Statistical analysis<br/> Data were analyzed using Review Manager (RevMan 5.3.5). Data were analyzed on an intention‐to‐treat basis, and treated dichotomously. In cross‐over studies, only data from the first arm were included. The primary endpoint was induction of remission, as defined by the studies. Data were combined for analysis if they assessed the same treatments (UFH or LMWH versus placebo or other therapy). If a comparison was only assessed in a single trial, P‐values were derived using the chi‐square test. If the comparison was assessed in more than one trial, summary test statistics were derived using the Peto risk ratio and 95% confidence intervals (95% CI). The presence of heterogeneity among studies was assessed using the chi‐square test (a P value of 0.10 was regarded as statistically significant). If statistically significant heterogeneity was identified the risk ratio and 95% CI were calculated using a random effects model. </p> <p>Quality assessment<br/> All authors independently assessed the risk of bias as described in the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD006774-bbs2-0037" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Factors assessed included: </p> <p> <ol id="CD006774-list-0001"> <li> <p>sequence generation (i.e. was the allocation sequence adequately generated?);</p> </li> <li> <p>allocation sequence concealment (i.e. was allocation adequately concealed?);</p> </li> <li> <p>blinding (i.e. was knowledge of the allocated intervention adequately prevented during the study?); </p> </li> <li> <p>incomplete outcome data (i.e. were incomplete outcome data adequately addressed?);</p> </li> <li> <p>selective outcome reporting (i.e. are reports of the study free of suggestion of selective outcome reporting?); and  </p> </li> <li> <p>other potential sources of bias (i.e. was the study apparently free of other problems that could put it at a high risk of bias?). </p> </li> </ol> </p> <p>A judgement of 'Yes' indicates low risk of bias, 'No' indicates high risk of bias, and 'Unclear' indicates unclear or unknown risk of bias. Disagreements were resolved by consensus. Study authors were contacted when insufficient information was provided to determine risk of bias. The overall quality of the evidence supporting the outcomes was evaluated using the GRADE criteria. </p> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006774-sec-0026" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006774-sec-0026"></div> <section id="CD006774-sec-0027"> <h3 class="title">Description of studies</h3> <p>The June 2014 literature identified a total of 35 full‐text articles (See <a href="#CD006774-fig-0001">Figure 1</a>). Of these, nine manuscripts representing five distinct trials met the inclusion criteria and were included in the review (<a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a>; <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>; <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>; <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>; <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a>). The June 2014 literature search did not identify any new studies for inclusion in the updated review. </p> <div class="figure" id="CD006774-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006774-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Three randomized, blinded studies published as abstracts only were excluded after attempts to contact the authors for further details about methodology and results were not successful (<a href="./references#CD006774-bbs2-0019" title="KorzenikJR , RobertME , BittonA , RobinsonM , ScherlEJ , FisherRL , et al. A multicenter, randomized, controlled trial of heparin for the treatment of ulcerative colitis. Gastroenterology1999;116(4 Part 2):A752. ">Korzenik 1999</a>; <a href="./references#CD006774-bbs2-0020" title="KorzenikJ , MinerP , StantonD , IssacsK , ZimmermanE , RiffD , et al. Multicenter, randomized, double‐blind, placebo‐controlled trial of deligoparin (ultra low molecular weight heparin) for active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. ">Korzenik 2003</a>; <a href="./references#CD006774-bbs2-0028" title="TorkvistL , StahlbergD , BohmanL , SjoqvistU , LoofL , JarnerotG , et al. LMWH for the treatment of mild to moderately active steroid refractory/dependent UC ‐ An independent, multicenter, randomised, controlled study. Gastroenterology2001;120(5 Suppl 1):A277. ">Torkvist 2001</a>). <a href="./references#CD006774-bbs2-0006" title="AngYS , MahmudN , WhiteB , ByrneM , KellyA , LawlerM , et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther2000;14(8):1015‐22. [PUBMED: 10930895] ">Ang 2000</a> enrolled patients with ulcerative colitis and Crohn's disease. This study was excluded because separate results were not provided for patients with ulcerative colitis. Seven papers were excluded for being case series (<a href="./references#CD006774-bbs2-0016" title="GaffneyPR , O'LearyJJ , DoyleCT , GaffneyA , HoganJ , SmewF , et al. Response to heparin in patients with ulcerative colitis. Lancet1991;337(8735):238‐9. [PUBMED: 1670865] ">Gaffney 1991</a>; <a href="./references#CD006774-bbs2-0017" title="GaffneyPR , DoyleCT , GaffneyA , HoganJ , HayesDP , AnnisP . Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol1995;90(2):220‐3. [PUBMED: 7847289] ">Gaffney 1995</a>; <a href="./references#CD006774-bbs2-0022" title="MiyakeY , SuwakiK , FujimotoT , HirohataM . Two cases of intractable ulcerative colitis with successful heparin treatment. Nippon Shokakibyo Gakkai Zasshi1998;95(9):1027‐31. [PUBMED: 9785894] ">Miyake 1998</a>; <a href="./references#CD006774-bbs2-0030" title="ZavgorodniiLG , MustiatsAP . Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis [Primenenie antikoaguliantov v kompleksnom lechenii nespetsificheskogo iazvennogo kolita]. Klin Med (Mosk)1982;60(6):74‐80. [PUBMED: 7120895] ">Zavgorodnii 1982</a>; <a href="./references#CD006774-bbs2-0031" title="ZhernalovaTV , KashmenskaiaNA , Mal'tsevaIV , PrigozhinaVK , FominIA . Hemostasis and heparin therapy in nonspecific ulcerative colitis. Sov Med1984, (2):110‐3. [PUBMED: 6719200] ">Zhernakova 1984</a>) or reports (<a href="./references#CD006774-bbs2-0025" title="ThorsteinssonGS , MagnusssonM , HallbergLM , WahlgrenNG , LindgrenF , MalmborgP , et al. Cerebral venous thrombosis and heparin‐induced thrombocytopenia in an 18‐year old male with severe ulcerative colitis. World J Gastroenterol2008;14(28):4576‐9. [PUBMED: 18680243] ">Thorsteinsson 2008</a>; <a href="./references#CD006774-bbs2-0018" title="IkehataA , YamakawaM , KitagawaM , FujiwaraT , MiuraT , OnoS , et al. A case of refractory ulcerative colitis treated successfully with a combination of low‐dose heparin and 5‐aminosalicylic acid. Nippon Shokakibyo Gakkai Zasshi2003;100(5):567‐71. [PUBMED: 12772571] ">Ikehata 2003</a>; <a href="./references#CD006774-bbs2-0021" title="MatsuzakiT , NakazawaT , NakazawaA , OtsukaS , MaedaN , YoneiY , et al. A case of ulcerative colitis (proctitis type) complicated with deep venous thrombosis and treated with heparin successfully. Nippon Shokakibyo Gakkai Zasshi2001;98(3):300‐6. [PUBMED: 11280908] ">Matsuzaki 2001</a>, <a href="./references#CD006774-bbs2-0010" title="DiFabioF , ObrandD , SatinR , GordonPH . Successful treatment of extensive splanchnic arterial and portal vein thrombosis associated with ulcerativecolitis. Colorectal Dis2009;11(6):653‐5. [PUBMED: 19175631] ">Di Fabio 2009</a>). The remaining studies were excluded as they were non‐randomized, open label studies (<a href="./references#CD006774-bbs2-0007" title="AshizukaS , NishiuraR , IshikawaN , YamagaJ , InatsuH , FujimotoS , et al. Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications. Ther Apher Dial2006;10(1):54‐8. [PUBMED: 16556137] ">Ashizuka 2006</a>; <a href="./references#CD006774-bbs2-0008" title="BrazierF , YzetT , BoruchowiczA , ColombelJF , DuchmannJC , DupasJL . Treatment of ulcerative colitis with heparin. Gastroenterology1996;110(Suppl):A782. ">Brazier 1996</a>; <a href="./references#CD006774-bbs2-0009" title="CuiHF , JiangXL . Treatment of corticosteroid‐resistant ulcerative colitis with oral low molecular weight heparin. World J Gastroenterol1999;5(5):448‐50. [PUBMED: 11819488] ">Cui 1999</a>; <a href="./references#CD006774-bbs2-0011" title="DotanI , HallakA , ArberN , SantoM , AlexandrowitzA , KnaaniY , et al. Low‐dose low‐molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci2001;46(10):2239‐44. [PUBMED: 11680603] ">Dotan 2001</a>; <a href="./references#CD006774-bbs2-0012" title="EvansRC , WongVS , MorrisAI , RhodesJM . Treatment of corticosteroid‐resistant ulcerative colitis with heparin ‐‐ a report of 16 cases. Aliment Pharmacol Ther1997;11(6):1037‐40. [PUBMED: 9663826] ">Evans 1997</a>; <a href="./references#CD006774-bbs2-0013" title="FolwacznyC , FrickeH , SpannaglM , LoeschkeK . Heparin for therapy of ulcerative colitis: therapy of a concomitant phenomenon or indication of pathophysiology?. Z Gastroenterol1995;33(12):723‐4. [PUBMED: 8585256] ">Folwaczny 1995</a>; <a href="./references#CD006774-bbs2-0014" title="FolwacznyC , FrickeH , EndresS , HartmannG , JochumM , LoeschkeK . Anti‐inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study. Am J Gastroenterol1997;92(5):911‐2. [PUBMED: 9149223] ">Folwaczny 1997</a>; <a href="./references#CD006774-bbs2-0015" title="FolwacznyC , WiebeckeB , LoeschkeK . Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol1999;94(6):1551‐5. [PUBMED: 10364024] ">Folwaczny 1999</a>;<a href="./references#CD006774-bbs2-0023" title="PastorelliL , SaibeniS , SpinaL , SignorelliC , CelascoG , deFranchisR , VecchiM . Oral, colonic‐release low‐molecular‐weight heparin: an initial open study of Parnaparin‐MMX for the treatment of mild‐to‐moderate left‐sided ulcerative colitis. Aliment Pharmacol Ther2008;28(5):581‐8. [PUBMED: 18700898] ">Pastorelli 2008</a>; <a href="./references#CD006774-bbs2-0024" title="SaibeniS , SpinaL , SignorelliC , PastorelliL , deFranchisR , MoroL , et al. Safety and efficacy of oral, colonic‐release, low molecular weight heparin‐MMX for the treatment of mild to moderate left‐sided ulcerative colitis: preliminary report of a pilot study. Gastroenterology2006;130(4 Suppl 2):A662. ">Saibeni 2006</a>; <a href="./references#CD006774-bbs2-0026" title="TorkvistL , ThorlaciusH , LapidusA , SjoqvistU , FloodL , AgrenB , et al. Low molecular weight heparin as adjuvant therapy in ulcerative colitis. Gastroenterology1998;114(4 Part 1):A1100‐1‐3. ">Torkvist 1998</a>; <a href="./references#CD006774-bbs2-0027" title="TorkvistL , ThorlaciusH , SjoqvistU , BohmanL , LapidusA , FloodL , et al. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther1999;13(10):1323‐8. [PUBMED: 10540047] ">Torkvist 1999</a>; <a href="./references#CD006774-bbs2-0029" title="VrijAA , JansenJM , SchoonEJ , deBruineA , HemkerHC , StockbruggerRW . Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol Suppl2001;36(234):41‐7. [PUBMED: 11768560] ">Vrij 2001</a>; See characteristics of excluded studies table). </p> <p><b>LMWH versus placebo</b> </p> <p><a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> <br/> This randomized, double‐blind trial included 100 patients (48 male, 52 female) with active ulcerative colitis. Active disease was defined by a clinical assessment of disease flare‐up and a minimum score of three on a combined score of bowel frequency, rectal bleeding, and procto‐sigmoidoscopy as defined in the paper. A histology score was added where available to give a baseline colitis activity score. The patients were randomized to subcutaneous tinzaparin 175 anti‐Xa IU/kg/day for two weeks, followed by subcutaneous tinzaparin 4500 anti‐Xa IU/day sc for four weeks (n = 48) or placebo (n = 52) subcutaneous injection daily for six weeks. Concurrent treatment with stable doses of salicylates or without improvement from increasing doses of salicylates was allowed, but no other therapies for ulcerative colitis were permitted. Patients underwent a sigmoidoscopy with biopsies within four days prior to randomization as well as within two to seven days after the end of the 42 days of treatment. The primary outcome measure was the degree of clinical improvement based on a change in the colitis activity score at the end of therapy compared to the baseline score. Complete response was defined as a colitis activity score of zero whereas a partial response was defined as a reduction of three points or more. Other outcome measures included numbers and percentages of patients in each category of activity score, quality of life scores using the Inflammatory Bowel Disease Questionnaire (IBDQ) (completed by patients in English speaking countries only), compliance with therapy, and adverse events. </p> <p><a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> <br/> This double‐blind, randomized trial included 141 patients (73 male, 68 female) with mild to moderately active left‐sided ulcerative colitis (defined by authors as a CAI ≥5 and ≤ 12) receiving stable‐dose oral aminosalicylate therapy. Patients were randomized to receive either an extended‐release 210 mg parnaparin sodium (87‐91 anti‐Xa U/mg) tablet that targets the colon or an identical placebo tablet every day for eight weeks while continuing their existing aminosalicylate regimens. Each patient underwent a colonoscopy, histologic evaluation and clinical assessment using the Clinical Activity Index (<a href="./references#CD006774-bbs2-0045" title="RachmilewitzD . Coated mesalazine (5‐aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ1989;298(6666):82‐6. [PUBMED: 2563951] ">Rachmilewitz 1989</a>) (CAI) no earlier than two weeks prior to entry. Clinical response was also measured at two, four and eight weeks with a second colonoscopy and histologic evaluation performed at the end of treatment. The primary outcome measure was clinical remission (CAI &lt;4) after eight weeks of treatment. Secondary outcome measures included clinical improvement (decrease in CAI by ≥ 2), endoscopic healing and improvement, histologic improvement, bleeding, and adverse events. </p> <p><a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a> <br/> This double‐blind, randomized trial included 29 patients (16 male, 13 female) with mild to moderately active ulcerative colitis (diagnosis based on Lennard‐Jones criteria) and a Truelove classification severity score of 4 to 14 were included. The patients were randomized to reviparin 3436 IU (n = 15) or placebo (n = 14) subcutaneous injections twice daily for up to eight weeks. All patients were concurrently treated with comparable stable doses of salicylates. Patients underwent a sigmoidoscopy with biopsies at baseline and after eight weeks, and were seen regularly during the eight week study period. A Clinical Symptom Grading and Colitis Activity Index (<a href="./references#CD006774-bbs2-0043" title="LichtigerS , PresentDH , KornbluthA , GelerntI , BauerJ , GallerG , et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med1994;330(26):1841‐5. [PUBMED: 8196726] ">Lichtiger 1994</a>) was calculated at each visit (<a href="./references#CD006774-bbs2-0043" title="LichtigerS , PresentDH , KornbluthA , GelerntI , BauerJ , GallerG , et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med1994;330(26):1841‐5. [PUBMED: 8196726] ">Lichtiger 1994</a>). If there was no improvement after four weeks or a clinical regression at any study visit the treatment was discontinued and corticosteroid therapy was initiated. The primary outcome measure was clinical improvement at the end of eight weeks where improvement was defined as a reduction in CAI by six points compared to baseline. Secondary outcomes included endoscopic and histologic improvements, and quality of life based on the IBDQ. </p> <p>Vrij 2007 describes the same cohort of patients as <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>. The main focus of this paper was whether clinical improvement with LMWH therapy was associated with reduced thrombin generation. Other hematological factors were also measured. Other outcome measures reported in this patient included the number of patients with clinical improvement after eight weeks, endoscopic and histologic improvement, and IBDQ results. </p> <p><b>LMWH in addition to standard therapy</b> </p> <p><a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a> <br/> This randomized non‐blinded trial included 34 patients (22 male, 12 female) with active ulcerative colitis (including 6 patients hospitalized at time of enrollment). Patients were randomized to two groups. The standard therapy group received corticosteroids and aminosalicylates (n = 18). The heparin therapy group received similar standard therapy plus subcutaneous enoxaparin 100 anti‐Xa IU/kg daily for 12 weeks (n = 16). For all patients the corticosteroids were initially administered either intravenously (prednisolone 50 to 75 mg/day) or orally (methylprednisolone 32 to 48 mg/day) depending on disease severity. After initial response, IV corticosteroids were switched to oral, and oral corticosteroids were tapered in a dose‐reduction schedule over 12 weeks. Aminosalicylates were given in steady doses (2 to 4 g/day) throughout the study. Patients underwent a colonoscopy at baseline, and were seen at regular intervals for clinical and biochemical assessments during the 12 week study period. Another colonoscopy was performed at the end of 12 weeks. Disease activity was assessed clinically with the Simple Clinical Colitis Activity Index (SCCAI) at each study visit. Endoscopic disease severity was assessed with a modified endoscopic grading system (scored 0 to 18). Histologic disease activity was scored from 0 to 12 based on four features (ulcers, erosion, crypt abscess, cryptitis). The primary outcome measures were the percentages of patients with complete responses (coexisting clinical and endoscopic remission, with SCCAI score &lt; 2 and endoscopic score &lt; 3) and partial responses (&gt; 50% reduction of SCCAI score and a reduction in endoscopic score by at least 1 grade) after 12 weeks of therapy in the "heparin therapy group" compared to the "standard therapy group". Other outcome measures included compliance and tolerability to therapy, withdrawals, adverse events, change in clinical, endoscopic, and histological disease activities and laboratory parameters of inflammation and coagulation. </p> <p><b>UFH versus corticosteroids</b> </p> <p><a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a> <br/> This single‐blind, randomized trial included 25 patients (12 male, 13 female) with moderate to severely active ulcerative colitis requiring hospitalization, with a Seo activity index of at least 150, and a sigmoidoscopic score of at least 2 on a 0 to 3 scale. Patients were stratified into moderate disease (Seo index 150 to 220) and severe disease (Seo index &gt; 220). Patients were randomized to a continuous infusion of UFH (n = 12; adjusted to achieve a prolongation of activated partial thromboplastin time (APTT) of 1.5 to 2 times control)) or a single daily dose of 6‐methylprednisolone 0.75 mg/kg/day (moderate disease) or 1 mg/kg/day (severe disease) plus a placebo infusion (n = 13). Physician assessors were blinded to the assigned therapies. Patients with significant improvement (decrease in Seo index &gt; 70 points) or remission (Seo index &lt; 100) were discharged from hospital on 12500 U of UFH twice daily or a tapering dose of steroids until week 12 of the study. Patients were seen regularly during hospital admission and after discharge. A sigmoidoscopy was performed at baseline, and at weeks four and eight. The primary outcome measure was clinical improvement (decrease in Seo index &gt; 70 points) at day 10. Patients not achieving this outcome or with a clinical worsening (increase in Seo index &gt; 70 points) at any point were considered treatment failures and withdrawn from the study. Secondary outcome measures included amount of rectal bleeding and changes in inflammatory markers on serial serology. </p> </section> <section id="CD006774-sec-0028"> <h3 class="title">Risk of bias in included studies</h3> <p><b>LMWH versus placebo</b> <br/> After obtaining further clarification from the authors (<a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a>; <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>; <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>), the overall risk of bias for the placebo‐controlled trials was determined to be low (See <a href="#CD006774-fig-0002">Figure 2</a>). The <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> and <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> studies were industry funded which is a potential source of bias. However, this potential source of bias probably does not have too much impact on the <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> study as the results were negative, showing no benefit for LMWH. </p> <div class="figure" id="CD006774-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD006774-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <p><b>LMWH in addition to standard therapy</b> </p> <p>After obtaining further information from the authors (<a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a>), the risk of bias was determined to be high for two key domains (allocation concealment and blinding). The study was non‐blinded but adequate methods were used for randomization. Although there is a higher risk of bias the overall interpretation of the results is not affected, as the study demonstrated no benefit for LMWH for the treatment of active ulcerative colitis (See <a href="#CD006774-fig-0002">Figure 2</a>). </p> <p><b>UFH versus corticosteroids</b> <br/> No further details regarding methodology were obtained from <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>. The risk of bias was determined to be unclear for two key domains (sequence generation and allocation concealment). Nonetheless, randomization was likely to be adequate in this study. The risk of bias for blinding was determined to be high because patients were not blinded. However, the study was single blind (physicians assessing the clinical state of the patients were blind). Despite the higher risk of bias in three key domains, the overall interpretation of the results is not affected, as the study demonstrated no benefit for UFH compared to corticosteroids which are of known efficacy (See <a href="#CD006774-fig-0002">Figure 2</a>). </p> </section> <section id="CD006774-sec-0029"> <h3 class="title" id="CD006774-sec-0029">Effects of interventions</h3> <p>See: <a href="./full#CD006774-tbl-0001"><b>Summary of findings for the main comparison</b> LMWH compared to Placebo for induction of remission in ulcerative colitis</a>; <a href="./full#CD006774-tbl-0002"><b>Summary of findings 2</b> LMWH + standard therapy compared to Standard therapy for induction of remission in ulcerative colitis</a>; <a href="./full#CD006774-tbl-0003"><b>Summary of findings 3</b> UFH compared to Corticosteroids for induction of remission in ulcerative colitis</a> </p> <p><b>LMWH versus placebo</b> </p> <p><b>Clinical remission</b> <br/> In <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> 4/48 patients (8.3%) assigned to LMWH and 4/52 patients (7.7%) assigned to placebo achieved clinical remission during the study period (RR 1.08; 95% CI 0.29 to 4.09; P = 0.91). In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 55/71 (77.5%) patients assigned to LMWH achieved clinical remission after 8 weeks of treatment compared to 39/70 patients (55.7%) in the placebo group (RR 1.39; 95% CI 1.09 to 1.77; P = 0.008). The studies were not pooled for analysis because the parenteral LMWH administered in <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> and the non‐parenteral LMWH administered in <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> exhibit different therapeutic profiles, locally and systemically. </p> <p><b>Endoscopic remission</b> <br/> In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 15/71 (21.1%) patients assigned to LMWH achieved endoscopic remission after 8 weeks of treatment compared to 11/70 (15.7%) patients in the placebo group (RR 1.34; 95% CI 0.66 to 2.72; P = 0.41). </p> <p><b>Clinical improvement</b> <br/> In <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> 15/48 patients (31.3%) assigned to LMWH and 20/52 patients (38.5%) assigned to placebo improved clinically over the study period (RR 0.81, 95% CI 0.47 to 1.40 , P = 0.45) during the study period. Over the study duration, the mean colitis activity score changed from 7.6 to 6.84 (‐10.0%) in the LMWH group and from 7.4 to 6.44 (‐13.0%) in the placebo group. In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 61/71 (85.9%) patients assigned to LMWH and 47/70 (67.1%) patients assigned to the placebo improved clinically (RR 1.28 ; 95% CI 1.06 to 1.55 ; P = 0.01). The mean CAI decreased from 6.22 to 2.02 in LMWH patients compared to a decrease from 6.64 to 2.96 in placebo patients over the treatment period. In <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a> 12/15 patients (80%) assigned to LMWH and 11/14 patients (78.6%) assigned to placebo clinically improved over the study period (RR 1.02; 95% CI 0.70 to 1.48; P = 0.92). The mean CAI decreased from 9.87 at baseline to 5 at week 8 in the LMWH group and from 9.14 to 6 in the placebo group. The mean Colitis Symptom Grading decreased from 8.33 at baseline to 4 in the LMWH group and from 6.36 to 4 in the placebo group. The definitions of clinical improvement in the <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a>, <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, and <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a> studies were not sufficiently similar to pool data for meta‐analysis. </p> <p><b>Endoscopic improvement</b> <br/> In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 59/71 (83.1%) patients in the LMWH group and 48/70 (68.6%) patients in the placebo group improved endoscopically over the study duration (RR 1.21 ; 95%CI 1.00 to 1.47; P = 0.05). The mean Endoscopic Index decreased from 5.93 to 2.47 in the LMWH group and from 6.24 to 3.44 in the placebo group. In <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a> 9/15 patients (60.0%) assigned to LMWH and 8/14 patients (57.1%) assigned to placebo improved endoscopically over the study period (RR 1.05 ; 95% CI 0.57 to 1.94 ; P = 0.88). The mean Endoscopic Grading System decreased from 9.64 at baseline to 7.36 after 8 weeks in the LMWH group and from 9.46 to 7.63 in the placebo group. The grading scales used in these two studies were not sufficiently similar to justify pooling the data for analysis. </p> <p><b>Endoscopic Remission</b> <br/> In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 15/71 (21.1%) patients in the LMWH group and 11/70 (15.7%) patients in the placebo group achieved endoscopic remission over the study duration (RR 1.34; 95% CI 0.66 to 2.72; P = 0.41). This outcome was not reported in <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>. </p> <p><b>Histological improvement</b> <br/> In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 33/71 (46.5%) patients in the LMWH group and 32/70 (45.7%) patients in the placebo group improved histologically over the study duration (RR 1.02 ; 95% CI 0.71 to 1.45; p = 0.93). The mean Histological Score decreased from 4.83 to 2.64 in the LMWH group and from 5.28 to 3.39 in the placebo group. In <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a> 10/15 patients (66.7%) assigned to LMWH and 7/14 patients (50%) assigned to placebo improved histologically over the study period (RR 1.33; 95% CI 0.71 to 2.51; P = 0.37). The mean Histological Grading System decreased from 2.93 at baseline to 2.00 after 8 weeks in the LMWH group and from 3.93 to 3.11 in the placebo group. The grading scales used in these two studies were not sufficiently similar to justify pooling the data for analysis. </p> <p><b>Adverse events</b> <br/> In <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> 0/48 patients (0%) assigned to LMWH and 1/52 patients (1.9%) assigned to placebo developed significant rectal hemorrhage. Other adverse events considered severe in the LMWH group included one patient with colitis not otherwise specified and two patients with aggravated ulcerative colitis; in the placebo group one patient had aggravated ulcerative colitis and one developed nausea. Overall 29/48 patients (60.4%) in the LMWH group and 28/52 patients (53.8%) in the placebo group reported at least one adverse event. No serious adverse events were reported in either the LMWH or placebo groups in <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>, including no reports of rectal hemorrhage. In <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>, 22/71 (31.0%) patients in the LMWH group and 23/70 (32.9%) patients in the placebo group experienced at least one adverse event during the study although none were serious. Bloody stools indicative of rectal bleeding were absent in 48/71 (67.6%) patients in the LMWH group and 35/70 (50.0%) patients in the placebo groups at 8 weeks compared to 2/71 (28.2%) and 3/70 (42.9%) at week 0, respectively. </p> <p><b>Quality of life</b> <br/> <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> reported the subscores of the different domains of the IBDQ, and found no significant differences in any domain between the LMWH and placebo groups from the start to the end of treatment. In <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>, there were no significant differences in the mean IBDQ score in the LMWH versus placebo group at baseline (LMWH 132.1, placebo 141.2, P = 0.57) or at the end of treatment (LMWH 162.1, placebo 173.1, P = 0.71). </p> <p><b>LMWH in addition to standard therapy</b> </p> <p><b>Clinical remission</b> <br/> In <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a> 5/16 patients (31.3%) assigned to LMWH in addition to standard therapy with corticosteroids and aminosalicylates and 7/18 patients (38.9%) assigned to standard therapy alone achieved clinical remission during the study period (RR 0.80; 95% CI 0.32 to 2.04 ; P = 0.64). </p> <p><b>Clinical improvement</b> <br/> In <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a> 14/16 patients (87.5%) assigned to LMWH in addition to standard therapy with corticosteroids and aminosalicylates and 14/18 patients (77.8%) assigned to standard therapy alone improved clinically during the study period (RR 1.13 ; 95% CI 0.83 to 1.53 ; P = 0.46). </p> <p><b>Endoscopic remission</b> <br/> In <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a> 5/16 patients (31.3%) assigned to LMWH in addition to standard therapy with corticosteroids and aminosalicylates and 7/18 patients (38.9%) assigned to standard therapy achieved endoscopic remission during the study period (RR 0.80 ; 95% CI 0.32 to 2.04; P = 0.64). </p> <p><b>Endoscopic improvement</b> <br/> In <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a> 11/16 patients (68.9%) assigned to LMWH in addition to standard therapy with corticosteroids and aminosalicylates and 11/18 patients (61.1%) assigned to standard therapy alone improved endoscopically during the study period (RR 1.13 ; 95% CI 0.69 to 1.85 ; P = 0.64). </p> <p><b>Histological improvement</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a>. </p> <p><b>Adverse events</b> <br/> In <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a>, no severe adverse events, including no significant rectal bleeding complications, occurred in patients in either the LMWH + standard therapy group nor in the standard therapy group. </p> <p><b>Quality of life</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a>. </p> <p><b>UFH versus corticosteroids</b> </p> <p><b>Clinical remission</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>. </p> <p><b>Endoscopic remission</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>. </p> <p><b>Clinical improvement</b> <br/> In <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a> 0/12 patients (0%) assigned to UFH and 9/13 patients (69.2%) assigned to corticosteroids improved clinically over the study period (RR 0.06; 95% CI 0 to 0.88; P = 0.04). </p> <p><b>Endoscopic improvement</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>. </p> <p><b>Histological improvement</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>. </p> <p><b>Adverse events</b> <br/> In <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>, three patients assigned to UFH were withdrawn from the study due to an increase in rectal bleeding. In 2 of these patients, the bleeding was controlled after stopping the UFH, but the third patient required urgent surgery. No other adverse events occurred in this group. One patient in the corticosteroid group required urgent surgery following the development of toxic megacolon. No other severe adverse events were reported. </p> <p><b>Quality of life</b> <br/> This outcome was not reported in <a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>. </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006774-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006774-sec-0030"></div> <p>There are a limited number of effective treatments for remission induction in active UC. An increased risk of thrombosis in patients with UC and reports suggesting an improvement in UC symptoms while on anticoagulant therapy led to randomized controlled studies of heparin and LMWH in active UC. However, an increased risk of rectal bleeding due to anticoagulant therapy would need to be considered as a potential complication of treatment, and balanced against any therapeutic benefit. </p> <p>There are four manuscripts reporting three distinct randomized, placebo‐controlled double blind studies evaluating LMWH in the treatment of outpatients with mild‐moderate active UC (<a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a>; <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a>; <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>; Vrij 2007). Two of these studies showed no benefit for adjuvant LMWH therapy over placebo in a variety of outcome measures, including clinical remission, clinical improvement, endoscopic improvement, histological improvement, or quality of life (<a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a>; <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>). However, the results of the <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> showed statistically significant benefit for LMWH over placebo in achieving clinical remission and improvement, endoscopic improvement, and reduced rectal bleeding when administered by extended colon ‐release tablets. </p> <p>The benefit of LMWH described by <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> may be due to the investigators' decision to study a LMWH administered via extended colon‐release tablets rather than through the conventional subcutaneous route. Oral LMWH is absorbed in the gastrointestinal tract , has enhanced efficacy in targeting GI lesions, and exerts a weaker systemic antithrombotic effect (<a href="./references#CD006774-bbs2-0041" title="LeverR , PageCP . Novel drug development opportunities for heparin. Nat Rev Drug Discov2002;1(2):140‐8. [PUBMED: 12120095] ">Lever 2002</a>). Taken together, these factors allowed <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> to administer a much higher dose of LMWH with a decreased risk of bleeding (18,000‐19,000 anti‐Xa IU versus 4500 anti‐Xa IU <a href="./references#CD006774-bbs2-0001" title="BloomS , KiilerichS , LassenM , O'MorainC , ForbesA , OrmS . Randomized trial of tinzaparin, a low molecular weight heparin (LMWH), versus placebo in the treatment of mild to moderately active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. BloomS , LiilerichS , LassenMR , ForbesA , LeiperK , LangholzE , et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther2004;19(8):871‐8. [PUBMED: 15080848] ">Bloom 2004</a> versus 3436 anti‐Xa IU <a href="./references#CD006774-bbs2-0003" title="VrijAA , Oberndorff‐Klein‐WoolthuisA , DijkstraG , deJongAE , WagenvoordR , HemkerHC , et al. Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin. J Thromb Thrombolysis2007;24(2):175‐82. [PUBMED: 17308963] deBievreMA , VrijAA , Oberndorff‐Klein WoolthuisAH , HemkerHC , StockbruggerRW . A randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A68. deBievreMA , VrijAA , SchoonEJ , DijkstraG , deJongAE , Oberndorff‐KleinAH , et al. Randomized, placebo‐controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis2007;13(6):753‐8. [PUBMED: 17260365] ">de Bievre 2007</a>) and deliver the drug directly to the diseased colon rather than have the drug systemically distributed to unaffected tissues. </p> <p>The two studies with negative findings enrolled relatively small numbers of patients, and may have lacked the power to detect a statistically significant difference between LMWH and placebo. However, the large difference in effect size between these studies weakens this hypothesis. Lastly, but of note, five of the eight <a href="./references#CD006774-bbs2-0002" title="CelascoG , PapaA , JonesR , MoroL , BozzellaR , SuraceMM , et al. Clinical trial: oral colon‐release parnaparin sodium tablets (CB‐01‐05 MMX) for active left‐sided ulcerative colitis. Aliment Pharmacol Ther2010;31(3):375‐86. [PUBMED: 19891665] ">Celasco 2010</a> investigators worked as consultants or employees for the firm that provided all study funding and developed the extended colon‐release technology. Despite being a well‐designed trial with thorough outcome reporting and analysis, the heavy degree of industry involvement is a potential source of bias which weakens the conclusions one can draw from the study. Empirical research has demonstrated that industry funded studies are more likely to be associated with positive results for the products made by the company funding the research (<a href="./references#CD006774-bbs2-0034" title="BHandariM , BusseJW , JackowskiD , MontoriVM , SchunemannH , SpragueS , et al. Association between industry funding and statistically significant pro‐industry findings in medical and surgical randomized trials. CMAJ2004;170(4):477‐80. [PUBMED: 14970094] ">Bhandari 2004</a>; <a href="./references#CD006774-bbs2-0042" title="LexchinJ , BeroLA , DjulbegovicB , ClarkO . Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ2003;326:1167‐70. [PUBMED: 12775614] ">Lexchin 2003</a>). </p> <p>No benefit was found with the addition of LMWH to standard therapy in <a href="./references#CD006774-bbs2-0005" title="ZezosP , PapaioannouG , NikolaidisN , PatsiaouraK , PapageorgiouA , VassiliadisT , et al. Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Aliment Pharmacol Ther2006;23(10):1443‐53. [PUBMED: 16669959] ">Zezos 2006</a>, in which participants and evaluators were not blinded to treatment allocation. However, LMWH was well‐tolerated in all of these studies, without any reports of significant rectal bleeding in those patients assigned to LMWH. Two other placebo‐controlled studies published as abstracts only also demonstrated no benefit for LMWH over placebo (<a href="./references#CD006774-bbs2-0020" title="KorzenikJ , MinerP , StantonD , IssacsK , ZimmermanE , RiffD , et al. Multicenter, randomized, double‐blind, placebo‐controlled trial of deligoparin (ultra low molecular weight heparin) for active ulcerative colitis. Gastroenterology2003;124(4 Suppl 1):A67. ">Korzenik 2003</a>; <a href="./references#CD006774-bbs2-0028" title="TorkvistL , StahlbergD , BohmanL , SjoqvistU , LoofL , JarnerotG , et al. LMWH for the treatment of mild to moderately active steroid refractory/dependent UC ‐ An independent, multicenter, randomised, controlled study. Gastroenterology2001;120(5 Suppl 1):A277. ">Torkvist 2001</a>). </p> <p>Only one of the included studies evaluated UFH monotherapy for active ulcerative colitis (<a href="./references#CD006774-bbs2-0004" title="PanesJ , EsteveM , CabreE , HinojosaJ , AndreuM , SansM , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;119(4):903‐8. [PUBMED: 11040177] PanesJ , EsteveM , CabreE , SansM , HinojosaJ , AndreuMG , et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology2000;118(4 Suppl 1):A874. ">Panes 2000</a>). This study included inpatients with severe disease, and corticosteroids were used as the comparator. The UFH‐treated patients had a significantly lower rate of clinical improvement than those who received steroids (0% versus 69%). Increased rectal bleeding also occurred in 3 of 12 patients given UFH. Although this study was limited by its single‐blind design, in that only the physician examiners were blinded to treatment allocation, the results strongly suggest inferiority of UFH compared to corticosteroids in this patient population. Furthermore, this study shows that UFH used as monotherapy does not provide any benefit for the treatment of moderate or severe exacerbations of ulcerative colitis. Whether or not UFH would be effective for treating patients with milder disease is not known. A single randomized, placebo‐controlled trial testing UFH in this setting has been published in abstract form only (<a href="./references#CD006774-bbs2-0019" title="KorzenikJR , RobertME , BittonA , RobinsonM , ScherlEJ , FisherRL , et al. A multicenter, randomized, controlled trial of heparin for the treatment of ulcerative colitis. Gastroenterology1999;116(4 Part 2):A752. ">Korzenik 1999</a>), but the final results have not been published. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD006774-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006774-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD006774-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus placebo, Outcome 1 Clinical remission." data-id="CD006774-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus placebo, Outcome 1 Clinical remission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus placebo, Outcome 2 Clinical improvement." data-id="CD006774-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus placebo, Outcome 2 Clinical improvement.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus placebo, Outcome 3 Endoscopic improvement." data-id="CD006774-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus placebo, Outcome 3 Endoscopic improvement.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus placebo, Outcome 4 Endoscopic remission." data-id="CD006774-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus placebo, Outcome 4 Endoscopic remission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 LMWH versus placebo, Outcome 5 Histological improvement." data-id="CD006774-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 LMWH versus placebo, Outcome 5 Histological improvement.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 1 Clinical remission." data-id="CD006774-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 1 Clinical remission.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 2 Clinical improvement." data-id="CD006774-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 2 Clinical improvement.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 3 Endoscopic remission." data-id="CD006774-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 3 Endoscopic remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 4 Endoscopic improvement." data-id="CD006774-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 LMWH + standard therapy versus standard therapy, Outcome 4 Endoscopic improvement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006774-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/urn:x-wiley:14651858:media:CD006774:CD006774-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_t/tCD006774-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 UFH versus corticosteroids, Outcome 1 Clinical improvement." data-id="CD006774-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 UFH versus corticosteroids, Outcome 1 Clinical improvement.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/media/CDSR/CD006774/image_n/nCD006774-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006774-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">LMWH compared to Placebo for induction of remission in ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>LMWH compared to Placebo for induction of remission in ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in ulcerative colitis<br/> <b>Settings:</b> Outpatient<br/> <b>Intervention:</b> LMWH<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> LMWH</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic remission</b> <br/> Follow‐up: mean 8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>157 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>211 per 1000</b> <br/> (104 to 427) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.34</b> <br/> (0.66 to 2.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>141<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control group risk comes from control arm of study<br/> <sup>2</sup> industry funded study and lack of sufficient details on central randomization<br/> <sup>3</sup> Very sparse data (26 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">LMWH compared to Placebo for induction of remission in ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006774-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">LMWH + standard therapy compared to Standard therapy for induction of remission in ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>LMWH + standard therapy compared to Standard therapy for induction of remission in ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in ulcerative colitis<br/> <b>Settings:</b> Outpatient<br/> <b>Intervention:</b> LMWH + standard therapy<br/> <b>Comparison:</b> Standard therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Standard therapy </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> LMWH + standard therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical remission</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>389 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>311 per 1000</b> <br/> (124 to 793) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.8</b> <br/> (0.32 to 2.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical improvement</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>879 per 1000</b> <br/> (646 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b> <br/> (0.83 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic remission</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>389 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>311 per 1000</b> <br/> (124 to 793) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.8</b> <br/> (0.32 to 2.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Endoscopic improvement</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>611 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>691 per 1000</b> <br/> (422 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b> <br/> (0.69 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control group risk comes from control arm of study<br/> <sup>2</sup> Open‐label trial (lack of blinding and allocation concealment)<br/> <sup>3</sup> Very sparse data (12 events)<br/> <sup>4</sup> Very sparse data (28 events)<br/> <sup>5</sup> Very sparse data (22 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">LMWH + standard therapy compared to Standard therapy for induction of remission in ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006774-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">UFH compared to Corticosteroids for induction of remission in ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>UFH compared to Corticosteroids for induction of remission in ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with induction of remission in ulcerative colitis<br/> <b>Settings:</b> Outpatient<br/> <b>Intervention:</b> UFH<br/> <b>Comparison:</b> Corticosteroids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Corticosteroids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> UFH</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical improvement</b> <br/> Follow‐up: mean 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>692 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (0 to 609) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.06</b> <br/> (0 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Control group risk comes from control arm of study<br/> <sup>2</sup> Single‐blind trial and lack of sufficient details on allocation concealment and randomization sequence<br/> <sup>3</sup> Very sparse data (9 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">UFH compared to Corticosteroids for induction of remission in ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/full#CD006774-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006774-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">LMWH versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endoscopic improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Endoscopic remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.66, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Histological improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">LMWH versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006774-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LMWH + standard therapy versus standard therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.32, 2.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.83, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endoscopic remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.32, 2.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Endoscopic improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.69, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">LMWH + standard therapy versus standard therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006774-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">UFH versus corticosteroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.00, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">UFH versus corticosteroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006774.pub4/references#CD006774-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006774.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006774-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006774-note-0005">فارسی</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006774\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006774\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006774\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006774\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006774\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006774.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006774.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006774.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006774.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006774.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719235784"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006774.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719235787"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006774.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de3cfc9d49368',t:'MTc0MDcxOTIzNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 